Cargando…

The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world

Since the first World Health Organization notification on 31 December 2019, coronavirus disease 2019 (COVID‐19), the respiratory disease caused by the coronavirus severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), has been responsible for over four million confirmed infections and almost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharpe, Hannah R., Gilbride, Ciaran, Allen, Elizabeth, Belij‐Rammerstorfer, Sandra, Bissett, Cameron, Ewer, Katie, Lambe, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283842/ https://www.ncbi.nlm.nih.gov/pubmed/32460358 http://dx.doi.org/10.1111/imm.13222

Ejemplares similares

The Integration of Human and Veterinary Studies for Better Understanding and Management of Crimean-Congo Haemorrhagic Fever
por: Gilbride, Ciaran, et al.
Publicado: (2021)

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
por: Spencer, Alexandra J., et al.
Publicado: (2021)

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
por: Sharpe, Hannah R., et al.
Publicado: (2022)

Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model
por: Saunders, Jack E., et al.
Publicado: (2023)

A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector
por: Sebastian, Sarah, et al.
Publicado: (2020)

A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
por: Lambe, Teresa, et al.
Publicado: (2017)

ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Insights Into the Changing Landscape of Coronavirus Disease 2019
por: Escobedo, Ruby A., et al.
Publicado: (2022)

Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
por: Madhavan, Meera, et al.
Publicado: (2022)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017)

Coronavirus Disease 2019: the Pivotal Role of UK Clinical Oncology and the UK Coronavirus Cancer Monitoring Project
por: Best, J., et al.
Publicado: (2021)

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials
por: Voysey, Merryn, et al.
Publicado: (2023)

Reduced Ebola vaccine responses in CMV(+) young adults is associated with expansion of CD57(+)KLRG1(+) T cells
por: Bowyer, Georgina, et al.
Publicado: (2020)

The UK national registry of ENT surgeons with coronavirus disease 2019
por: Stephenson, K, et al.
Publicado: (2020)

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
por: Flaxman, Amy, et al.
Publicado: (2021)

Coronavirus disease 2019 vaccines: landscape of global studies and potential risks
por: Jiang, Hu-Da-Chuan, et al.
Publicado: (2021)

Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine
por: Watanabe, Yasunori, et al.
Publicado: (2021)

Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine
por: Watanabe, Yasunori, et al.
Publicado: (2021)

The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2
por: Zhu, James, et al.
Publicado: (2020)

The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes
por: Tang, Guoxing, et al.
Publicado: (2021)

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
por: Lambe, Teresa, et al.
Publicado: (2021)

Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
por: Graham, Simon P., et al.
Publicado: (2020)

Geriatrics in the Rest of the World
por: Woo, Jean
Publicado: (2010)

Metabolic Landscape of Bronchoalveolar Lavage Fluid in Coronavirus Disease 2019 at Single Cell Resolution
por: Shao, Ming-Ming, et al.
Publicado: (2022)

Invasive Pulmonary Aspergillosis in Coronavirus Disease 2019 Patients Lights and Shadows in the Current Landscape
por: Tsotsolis, Stavros, et al.
Publicado: (2023)

Why do the impacts of coronavirus disease 2019 and the response surprise the world?
por: Raju, Emmanuel, et al.
Publicado: (2020)

Energy landscapes of resting-state brain networks
por: Watanabe, Takamitsu, et al.
Publicado: (2014)

Efficacy of ChAdOx1 vaccines against SARS-CoV-2 Variants of Concern Beta, Delta and Omicron in the Syrian hamster model
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

The unique landscape of coronavirus disease 2019 coagulopathy and imminent bleedings at unusual sites: Pathophysiology matters
por: Paschou, Eleni, et al.
Publicado: (2022)

UK GAAP 2019
por: LLP, Ernst & Young
Publicado: (2019)

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
por: Folegatti, Pedro M, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19) cuts ties with patients' outside world()
por: Freeman-Sanderson, Amy, et al.
Publicado: (2020)

Estimating the Prevalence and Mortality of Coronavirus Disease 2019 (COVID-19) in the USA, the UK, Russia, and India
por: Wang, Yongbin, et al.
Publicado: (2020)

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
por: Pinato, David J., et al.
Publicado: (2021)

Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK Biobank
por: Topless, Ruth K., et al.
Publicado: (2021)

Visualising and quantifying ‘excess deaths’ in Scotland compared with the rest of the UK and the rest of Western Europe
por: Minton, Jon, et al.
Publicado: (2017)

ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

Landscape Profiling Analysis of DPP4 in Malignancies: Therapeutic Implication for Tumor Patients With Coronavirus Disease 2019
por: Shu, Lingling, et al.
Publicado: (2021)

Emergency Nursing Care of Patients With Novel Coronavirus Disease 2019
por: Deitrick, Katie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rkep5bhd1girv4oinn1hdd1e51